PI
ARNA

PEAK6 Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History

PEAK6 Investments’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,000
Closed -$630K – 5100
2020
Q2 		$630K Buy
+10,000
New +$550K ﹤0.01% 2486

Other funds holding ARNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

PEAK6 Investments's ARNA Position: Q1 2020 in Review

PEAK6 Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2020, closing a stake of 4,443 shares — an estimated $202K sold.

PEAK6 Investments first reported a position in ARNA in Q3 2018 and held it in 6 quarters. The position peaked at $366K in Q4 2018. 219 funds tracked by Wall St. Rank hold ARNA as of Q1 2020.

  • PEAK6 Investments reported no remaining Arena Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
  • PEAK6 Investments sold 4,443 Arena Pharmaceuticals Inc shares in Q1 2020, an estimated $202K.
  • PEAK6 Investments first reported a position in Arena Pharmaceuticals Inc in Q3 2018 and held it in 6 quarters.
  • PEAK6 Investments's Arena Pharmaceuticals Inc position peaked at $366K in Q4 2018.
  • 219 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2020.

Based on PEAK6 Investments's 13F filing for Q1 2020, filed 14 May 2020.